CompletedNCT06060210
Ketamine and mood symptoms during shunt surgery
About this title
Read the official source — NCT06060210Medication studyAges 20–44EgyptDepression
Understand this study
Who was this study for?
Listed age limits: 20 years to 44 years.
- Listed locations
- BanhāSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: October 29, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 110
- Sponsor
- Benha University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Egypt
- Age range
- From 20 Years to 44 Years
- Official registry ID
- NCT06060210
- Official title
Show the full official title
Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion. A Randomized Double-blind Controlled Trial.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Banhā
Questions about this study
Who is behind this study?
The study sponsor is Benha University, a university.
Did this study involve medication?
Yes. The study involved medication, including normal Saline and ketamine.
Who was this study for?
Listed age limits: 20 years to 44 years.
